NEW YORK (GenomeWeb News) - Siemens Healthcare and Laboratory Corporation of America have agreed to "discuss future possibilities" to co-develop clinical diagnostic tests, the companies said today.
 
The non-exclusive agreement encompasses the areas of metabolic syndrome, oncology, diabetes, and companion diagnostics that are "designed to identify the suitability between patients and a particular drug therapy," the partners said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.